Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate,umeclidinium,vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 15/11/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Dermatitis, Atopic, Date of authorisation: 17/06/2021, Revision: 4, Status: Authorised

Mefloquine: List of nationally authorised medicinal products - PSUSA/00000304/202303

Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Graft Rejection, Date of authorisation: 23/04/2007, Revision: 26, Status: Authorised

SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, from 12/10/2023 to 12/10/2023

SPOR and xEVMPD Stakeholder Engagement Webinars : Organisation Management Service (OMS), Online, from 04/10/2023 to 04/10/2023

SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD), Online, from 10/10/2023 to 10/10/2023

SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data Governance, Online, from 02/10/2023 to 02/10/2023

CTIS newsflash – 27 October 2023

CTIS newsflash – 13 October 2023